Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Actinium Pharmaceuticals Inc. | 3 | 0 | 0 | 0 | €7.50 | €8.50 | 13.333% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.25 | €10.00 | 60.000% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €49.61 | €55.00 | 10.865% |
| AbbVie Inc. | 22 | 0 | 2 | 0 | €144.38 | €175.11 | 21.285% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €5.95 | - | - |
| MacroGenics Inc. | 13 | 0 | 4 | 0 | €3.84 | €12.42 | 223.729% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €6.08 | €11.05 | 81.697% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €136.80 | €184.76 | 35.058% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €138.50 | €236.30 | 70.612% |
| TG Therapeutics Inc. | 22 | 4 | 2 | 0 | €15.15 | €28.06 | 85.220% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €38.06 | €70.00 | 83.920% |
| Eli Lilly Corp. | 50 | 0 | 7 | 0 | €752.70 | €786.51 | 4.491% |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €2.11 | €8.55 | 305.000% |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.71 | €4.62 | -2.058% |
| Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.32 | €12.18 | 424.931% |
| VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.60 | €3.00 | 401.672% |
| Adverum Biotechnologies Inc. | 7 | 0 | 2 | 0 | €1.38 | €5.60 | 305.913% |
| Biolife Solutions Inc | 1 | 0 | 1 | 0 | €20.00 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €68.44 | €100.00 | 46.113% |
| Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €33.80 | €45.98 | 36.036% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.17 | €3.70 | 216.781% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €115.00 | €124.92 | 8.628% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.88 | €24.13 | 62.185% |
| Verastem Inc. | 13 | 0 | 5 | 0 | €3.70 | €19.95 | 439.214% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €2.06 | €4.16 | 101.609% |